Inhibitor of CD59 Activity as an Adjunct to Antibody-Based Cancer Therapy

Summary A bacterial peptide fragment has been shown to facilitate antibody-mediated and complement-dependant cancer cytolysis.

Applications Contact Maryanne Fenerjian, PhD Office of Technology Development Tel: 617-432-3845 Email: [email protected] For Further Information Please Contact the Director of Business Development Alex Szidon Email: [email protected] Telephone: (617) 495-3067

Inventor(s): Qin, Xuebin

Type of Offer: Licensing



« More Medical Patents

---